Screening and prevention of hepatitis C virus reactivation during chemotherapy

Hepatitis C virus (HCV) reactivation occurs in 23% of HCV-infected cancer patients receiving chemotherapy. Forty-three percent of the patients with reactivation of HCV during chemotherapy develop a hepatitis flare. Most of the cancer patients with HCV reactivation have an unremarkable clinical cours...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan-Rung, Hu, Tsung-Hui, Chen, Wen-Chi, Hsu, Ping-I, Chen, Hui-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384748/
https://www.ncbi.nlm.nih.gov/pubmed/34497443
http://dx.doi.org/10.3748/wjg.v27.i31.5181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384748/
https://www.ncbi.nlm.nih.gov/pubmed/34497443
http://dx.doi.org/10.3748/wjg.v27.i31.5181

Ejemplares similares